Addressing the Evidence Gap in Aneurysmal Subarachnoid Hemorrhage: The Need for a Pragmatic Randomized Trial Platform
Stroke · 2024
DOI: 10.1161/strokeaha.124.048089 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stroke, 2024. Verfasst von Hooman Kamel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurocritical Care, Weill Cornell Medicine, New York, NY (H.K.). Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
Aneurysmal subarachnoid hemorrhage (aSAH) occurs less often than other stroke types but affects younger patients, imposing a disproportionately high burden of long-term disability. Although management advances have improved outcomes over time, relatively few aSAH treatments have been tested in randomized clinical trials (RCTs). One lesson learned from COVID-19 is that trial platforms can facilitate the efficient execution of multicenter RCTs even in complex diseases during challenging conditions. An aSAH trial platform with standardized eligibility criteria, randomization procedures, and end point definitions would enable the study of multiple targeted interventions in a perpetual manner, with treatments entering and leaving the platform based on predefined decision algorithms. An umbrella institutional review board protocol and clinical trial agreement would allow individual arms to be efficiently added as amendments rather than stand-alone protocols. Standardized case report forms using the National Institutes of Health/National Institute of Neurological Disorders and Stroke common data elements and general protocol standardization across arms would create synergies for data management and monitoring. A Bayesian analysis framework would emphasize frequent interim looks to enable early termination of trial arms for futility, common controls, borrowing of information across arms, and adaptive designs. A protocol development committee would assist investigators and encourage pragmatic designs to maximize generalizability, reduce site burden, and execute trials efficiently and cost-effectively. Despite decades of steady clinical progress in the management of aSAH, poor patient outcomes remain common, and despite the increasing availability of RCT data in other fields, it remains difficult to perform RCTs to guide more effective care for aSAH. The development of a platform for pragmatic RCTs in aSAH would help close the evidence gap between aSAH and other stroke types and improve outcomes for this important disease with its disproportionate public health burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Neurocritical Care, Weill Cornell Medicine, New York, NY (H.K.).
- Division of Neurosciences Critical Care, Johns Hopkins University School of Medicine, Baltimore, MD (J.I.S.).
- Department of Neurosurgery, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY (E.S.C.).
- Department of Neurosurgery, University Hospitals Cleveland Medical Center/Case Western Reserve University School of Medicine (S.A.-H.).
- Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles (W.T.M.).
- Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL (S.H.-Y.C.).
ORCID-Profile: Hooman Kamel, Sepideh Amin-Hanjani, William T Mack, Sherry Hsiang-Yi Chou, Katharina M Busl, Colin P Derdeyn, Jordan E Elm
Förderung
- NINDS NIH HHS
Zitieren
APA
Kamel, H., Suarez, J. I., Connolly, E. S., Amin-Hanjani, S., Mack, W. T., Chou, S. H., Busl, K. M., Derdeyn, C. P., Dangayach, N. S., Elm, J. E., Beall, J., & Ko, N. U. (2024). Addressing the Evidence Gap in Aneurysmal Subarachnoid Hemorrhage: The Need for a Pragmatic Randomized Trial Platform. Stroke. https://doi.org/10.1161/strokeaha.124.048089
Vancouver
Kamel H, Suarez JI, Connolly ES, Amin-Hanjani S, Mack WT, Chou SH, et al. Addressing the Evidence Gap in Aneurysmal Subarachnoid Hemorrhage: The Need for a Pragmatic Randomized Trial Platform. Stroke. 2024. doi:10.1161/strokeaha.124.048089
BibTeX
@article{Kamel2024,
author = {Kamel, Hooman and Suarez, Jose I and Connolly, E Sander and Amin-Hanjani, Sepideh and Mack, William T and Chou, Sherry Hsiang-Yi and Busl, Katharina M and Derdeyn, Colin P and Dangayach, Neha S and Elm, Jordan E and Beall, Jonathan and Ko, Nerissa U},
title = {Addressing the Evidence Gap in Aneurysmal Subarachnoid Hemorrhage: The Need for a Pragmatic Randomized Trial Platform},
journal = {Stroke},
year = {2024},
doi = {10.1161/strokeaha.124.048089}
}
EUVIMED